SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hunder GG. Giant-cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997; 81: 195219.
  • 2
    Cid MC, Font C, Coll-Vinent B, Grau JM. Large vessel vasculitides. Curr Opin Rheumatol 1998; 10: 1828.
  • 3
    Weyand CM, Goronzy JJ. Giant-cell arteritis as an antigen-driven disease. Rheum Dis Clin North Am 1995; 21: 102739.
  • 4
    Cid MC, Campo E, Ercilla G, Palacin A, Vilaseca A, Villalta J, et al. Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis: influence of corticosteroid treatment. Arthritis Rheum 1989; 32: 88493.
  • 5
    Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant-cell arteritis. Ann Intern Med 1996; 121: 48491.
  • 6
    Weyand CM, Schonberger J, Oppitz U, Hunder GG, Hicok KC, Goronzy JJ. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 1994; 179: 95160.
  • 7
    Frennette PS, Wagner DD. Adhesion molecules. Part I. N Engl J Med 1996; 334: 15269.
  • 8
    Frennette PS, Wagner DD. Adhesion molecules. Part II. N Engl J Med 1996; 335: 435.
  • 9
    Mojcik CF, Shevach EM. Adhesion molecules: a rheumatologic perspective. Arthritis Rheum 1997; 40: 9911004.
  • 10
    Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 82772.
  • 11
    Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 30114.
  • 12
    Cid MC, Esparza J, Juan M, Miralles A, Ordi J, Vilella R, et al. Signaling through CD50 (ICAM-3) stimulates T lymphocyte binding to human umbilical vein endothelial cells and extracellular matrix proteins via an increase in β1 and β2 integrin function. Eur J Immunol 1994; 24: 137782.
  • 13
    Cronstein BN, Kimmel SC, Levin IR, Martiniuk F, Weissman G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial cell-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1992; 89: 99915.
  • 14
    Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 1994; 93: 1725.
  • 15
    Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM. Cell 1993; 74: 18595.
  • 16
    Piali L, Hammael P, Wherek C, Bachmann F, Gisler RH, Dunon D, et al. CD31/PECAM-1 is a ligand for αvβ3 integrin involved in adhesion of leukocytes to endothelial cells. J Cell Biol 1995; 130: 45160.
  • 17
    Cid MC. New developments in the pathogenesis of systemic vasculitis. Curr Opin Rheumatol 1996; 8: 111.
  • 18
    Argenbright LW, Barton RW. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo: the Shwartzman reaction revisited. J Clin Invest 1992; 89: 25972.
  • 19
    Mayet WJ, Schwarting A, Orth T, Duchman R, Meyer zum Buschenfelde KH. Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1). Clin Exp Immunol 1996; 103: 25967.
  • 20
    Panegyres PK, Faull RJ, Russ G, Appleton SL, Wangel AG, Blumbergs PC. Endothelial cell activation in vasculitis of peripheral nerve and skeletal muscle. J Neurol Neurosurg Psychiatry 1991; 55: 47.
  • 21
    Rastaldi MP, Ferrario F, Tunesi S, Yang L, D'Amico G. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1 alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis. Am J Kidney Dis 1996; 27: 4857.
  • 22
    Wawryk SO, Ayberk H, Boyd AW, Rode J. Analysis of adhesion molecules in the immunopathogenesis of giant-cell arteritis. J Clin Pathol 1991; 44: 497501.
  • 23
    Sais G, Vidaller A, Jugcla A, Condom E, Peyri J. Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis: an immunohistologic and clinical study in 42 patients. Arch Dermatol 1997; 133: 44350.
  • 24
    Burrows NP, Molma FA, Terenghi G, Clark PK, Haskard DO, Polak JM, et al. Comparison of cell adhesion molecule expression in cutaneous leukocytoclastic and lymphocytic vasculitis. J Clin Pathol 1994; 47: 93944.
  • 25
    Leung DYM, Kurt-Jones E, Newburger JW, Cotran RS, Burns JC, Pober JS. Endothelial cell activation and increased interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1990; 339: 1298302.
  • 26
    Coll-Vinent B, Cebrián M, Cid MC, Font C, Esparza J, Juan M, et al. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Arthritis Rheum 1998; 41: 43544.
  • 27
    Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, López-Soto A, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998; 41: 2632.
  • 28
    Cordell J, Falini B, Erber W, Gosh A, Abdulariz Z, MacDonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immunocomplexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 21929.
  • 29
    Van der Waal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 1992; 141: 142733.
  • 30
    Möst J, Neumayer HP, Dierich MP. Cytokine-induced generation of multinucleated giant cells in vitro requires IFNγ and expression of LFA-1. Eur J Immunol 1990; 20: 16617.
  • 31
    Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6: 25919.
  • 32
    Terol MJ, Cid MC, López-Guillermo A, Juan M, Yagüe J, Miralles A, et al. Expression of intercellular adhesion molecule-3 (ICAM-3/CD50) in malignant lymphoproliferative disorders and solid tumors. Tissue Antigens 1996; 48: 2717.
  • 33
    Koch AE. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 1998; 41: 95162.
  • 34
    El-Gabalawy H, Canvin J, Ma GM, van der Vieren M, Hoffman P, Gallatin M, et al. Synovial distribution of αd/CD18, a novel leukointegrin: comparison with other integrins and their ligands. Arthritis Rheum 1996; 39: 191321.
  • 35
    Weyand CM, Wagner AD, Björnsson J, Goronzy JJ. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant-cell arteritis. J Clin Invest 1996; 98: 16429.
  • 36
    Weyand CM, Tetzlaff N, Björnsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997; 40: 1926.
  • 37
    Del Pozo MA, Cabañas C, Montoya MC, Ager A, Sánchez-Mateos P, Sánchez-Madrid F. ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. J Cell Biol 1997; 137: 493508.
  • 38
    Del Pozo MA, Sánchez-Mateos P, Sánchez-Madrid F. Cellular polarization induced by chemokines: a mechanism for leukocyte recruitment? Immunol Today 1996; 17: 12731.
  • 39
    Campanero MR, Sánchez-Mateos P, del Pozo MA, Sánchez-Madrid F. ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands. J Cell Biol 1994; 127: 86778.
  • 40
    Hernández-Rodríguez J, Aguilera E, Grau JM, Cardellach F, Cid MC. Pernicious anemia in a patient with giant-cell arteritis in long-term remission [letter]. Clin Exp Rheumatol 1999; 17: 128.
  • 41
    Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant-cell (temporal) arteritis. Ann Intern Med 1995; 122: 5027.
  • 42
    Youssef PP, Triantafillou S, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ, et al. Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis: reduced E-selectin and intercellular adhesion molecule 1 expression. Arthritis Rheum 1996; 39: 19709.
  • 43
    Meliconi R, Pulsatelli L, Melchiorri C, Frizziero L, Salvarani C, Macchioni P, et al. Synovial expression of cell adhesion molecules in polymyalgia rheumatica. Clin Exp Immunol 1997; 107: 494500.
  • 44
    Barnes PJ, Karin M. Nuclear factor κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 106671.
  • 45
    Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 1997; 99: 284250.
  • 46
    Paul LC, Davidoff A, Benediktsson H, Issekutz TB. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts. Transplant Proc 1993; 25: 8134.
  • 47
    Bullard DC, King PD, Hicks MJ, Dupont B, Beaudet AL, Elkon KB. Intercellular adhesion molecule-1 deficiency protects MRL/Mpj-Fas (lpr) mice from early lethality. J Immunol 1997; 159: 205867.
  • 48
    Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 1994; 37: 9929.
  • 49
    Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 175763.